SOURCE ARCHIVE · ORIGINAL LINKS INCLUDED
Boston Scientific acquired Valencia Technologies to expand treatment options for overactive bladder and urge urinary incontinence using the eCoin System, a minimally invasive tibial neurostimulation therapy.
Benign prostatic hyperplasia (BPH) affects up to 90% of men by age 85, causing urinary issues. Boston Scientific highlights minimally invasive treatments like Rezūm, GreenLight XPS, and HoLEP to manage symptoms without...
Boston Scientific announced positive results from the FRACTURE IDE trial for the SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter, meeting primary safety and effectiveness endpoints in treating severe coronary...
Boston Scientific invested $1.5 billion for a 34% stake in MiRus LLC, gaining an option to fully acquire its TAVR valve system pending milestones. The SIEGEL valve, a nickel-free device, aims to improve treatment for...
Colorectal cancer rates are rising among younger adults, with liver metastases affecting over half of U.S. cases annually. New therapies like Hepatic Artery Infusion and TheraSphere are expanding treatment options for...
Boston Scientific presented clinical data at Heart Rhythm 2026 supporting the safety and effectiveness of its FARAPULSE Pulsed Field Ablation Platform and WATCHMAN Left Atrial Appendage Closure devices across multiple...